FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2009352205> ?p ?o ?g. }

• W2009352205 endingPage "680" @default.
• W2009352205 startingPage "671" @default.
• W2009352205 abstract "Upon ingestion ethylene glycol (EG, monoethylene glycol) is rapidly absorbed from the gastrointestinal tract, and depending on the severity of exposure signs of toxicity may progress through three stages. Neurological effects characterize the first step consisting of central nervous depression (intoxication, lethargy, seizures, and coma). The second stage, usually 12-24 h after ingestion, is characterized by metabolic acidosis due to the accumulation of acidic metabolites of EG, primarily glycolic acid (GA), contributing to the ensuing osmolal and anion gaps. Stage 3, generally 24-72 h after ingestion, is determined mainly by oxalic acid excretion, nephropathy, and eventual renal failure. Because the toxicity of EG is mediated principally through its metabolites, adequate analytical methods are essential to provide the information necessary for diagnosis and therapeutic management. The severe metabolic acidosis and multiple organ failure caused by ingestion of high doses of EG is a medical emergency that usually requires immediate measures to support respiration, correct the electrolyte imbalance, and initiate hemodialysis. Since metabolic acidosis is not specific to EG, whenever EG intoxication is suspected, every effort should be made to determine EG as well as its major metabolite GA in plasma to confirm the diagnosis and to institute special treatment without delay. A number of specific and sensitive analytical methods (GC, GC-MS, or HPLC) are available for this purpose. Due to the rapid metabolism of EG, the plasma concentration of GA may be higher than that of EG already upon admission. As toxicity is largely a consequence of metabolism of EG to GA and oxalic acid, the simultaneous quantification of EG and GA is important. Formation of calcium oxalate monohydrate in the urine may be a useful indicator of developing oxalate nephrosis although urine crystals can result without renal injury. The pathways involved in the metabolism of EG are qualitatively similar in humans and laboratory animals, although quantitative differences have been reported. Comparison between species is difficult, however, because the information on humans is derived mainly from acute poisoning cases whereas the effects of repeated exposures have been investigated in animal experiments. Based on published data the minimum human lethal dose of EG has been estimated at approx. 100 ml for a 70-kg adult or 1.6 g/kg body weight (calculation of dose in ml/kg to mg/kg based in EG density=1.11 g/l). However, human data from case reports are generally insufficient for the determination of a clear dose-response relationship and quantification of threshold doses for systemic toxicity, in particular renal effects, is limited. As toxicity is largely a consequence of metabolism of EG to GA, it is important to note that no signs of renal injury have developed at initial plasma glycolate concentrations of up to 10.1 mM (76.7 mg/dl). Plasma EG levels of 3.2 mM (20 mg/dl) are considered the threshold of toxicity for systemic exposure, if therapeutic strategy is based on the EG concentration alone." @default.
• W2009352205 created "2016-06-24" @default.
• W2009352205 creator A5038916027 @default.
• W2009352205 creator A5051491025 @default.
• W2009352205 creator A5082056850 @default.
• W2009352205 date "2004-09-15" @default.
• W2009352205 modified "2023-09-23" @default.
• W2009352205 title "Ethylene glycol: an estimate of tolerable levels of exposure based on a review of animal and human data" @default.
• W2009352205 cites W113687629 @default.
• W2009352205 cites W134872661 @default.
• W2009352205 cites W1827869947 @default.
• W2009352205 cites W1908314424 @default.
• W2009352205 cites W1949947788 @default.
• W2009352205 cites W1972903238 @default.
• W2009352205 cites W1976934346 @default.
• W2009352205 cites W1980284387 @default.
• W2009352205 cites W1988713570 @default.
• W2009352205 cites W1995820856 @default.
• W2009352205 cites W2005129242 @default.
• W2009352205 cites W2005483221 @default.
• W2009352205 cites W2020536843 @default.
• W2009352205 cites W2033122117 @default.
• W2009352205 cites W2034235059 @default.
• W2009352205 cites W2039723909 @default.
• W2009352205 cites W2040396932 @default.
• W2009352205 cites W2055542932 @default.
• W2009352205 cites W2066438516 @default.
• W2009352205 cites W2069196898 @default.
• W2009352205 cites W2074605171 @default.
• W2009352205 cites W2079960851 @default.
• W2009352205 cites W2089005693 @default.
• W2009352205 cites W2090336169 @default.
• W2009352205 cites W2094206309 @default.
• W2009352205 cites W2097295289 @default.
• W2009352205 cites W2099203786 @default.
• W2009352205 cites W2103836396 @default.
• W2009352205 cites W2112810068 @default.
• W2009352205 cites W2113589348 @default.
• W2009352205 cites W2117504678 @default.
• W2009352205 cites W2126353389 @default.
• W2009352205 cites W2140852252 @default.
• W2009352205 cites W2144037952 @default.
• W2009352205 cites W2157955883 @default.
• W2009352205 cites W2168507503 @default.
• W2009352205 cites W2279638740 @default.
• W2009352205 cites W2313856264 @default.
• W2009352205 cites W2322575514 @default.
• W2009352205 cites W2324516510 @default.
• W2009352205 cites W2417755118 @default.
• W2009352205 cites W4230880107 @default.
• W2009352205 cites W4297951880 @default.
• W2009352205 cites W4301719727 @default.
• W2009352205 cites W72220115 @default.
• W2009352205 doi "https://doi.org/10.1007/s00204-004-0594-8" @default.
• W2009352205 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15372138" @default.
• W2009352205 hasPublicationYear "2004" @default.
• W2009352205 type Work @default.
• W2009352205 sameAs 2009352205 @default.
• W2009352205 citedByCount "48" @default.
• W2009352205 countsByYear W20093522052012 @default.
• W2009352205 countsByYear W20093522052013 @default.
• W2009352205 countsByYear W20093522052014 @default.
• W2009352205 countsByYear W20093522052015 @default.
• W2009352205 countsByYear W20093522052016 @default.
• W2009352205 countsByYear W20093522052017 @default.
• W2009352205 countsByYear W20093522052018 @default.
• W2009352205 countsByYear W20093522052020 @default.
• W2009352205 countsByYear W20093522052021 @default.
• W2009352205 countsByYear W20093522052022 @default.
• W2009352205 countsByYear W20093522052023 @default.
• W2009352205 crossrefType "journal-article" @default.
• W2009352205 hasAuthorship W2009352205A5038916027 @default.
• W2009352205 hasAuthorship W2009352205A5051491025 @default.
• W2009352205 hasAuthorship W2009352205A5082056850 @default.
• W2009352205 hasBestOaLocation W20093522052 @default.
• W2009352205 hasConcept C126322002 @default.
• W2009352205 hasConcept C185592680 @default.
• W2009352205 hasConcept C193230392 @default.
• W2009352205 hasConcept C2777260799 @default.
• W2009352205 hasConcept C2777477808 @default.
• W2009352205 hasConcept C2779246250 @default.
• W2009352205 hasConcept C29730261 @default.
• W2009352205 hasConcept C42407357 @default.
• W2009352205 hasConcept C71924100 @default.
• W2009352205 hasConcept C98274493 @default.
• W2009352205 hasConceptScore W2009352205C126322002 @default.
• W2009352205 hasConceptScore W2009352205C185592680 @default.
• W2009352205 hasConceptScore W2009352205C193230392 @default.
• W2009352205 hasConceptScore W2009352205C2777260799 @default.
• W2009352205 hasConceptScore W2009352205C2777477808 @default.
• W2009352205 hasConceptScore W2009352205C2779246250 @default.
• W2009352205 hasConceptScore W2009352205C29730261 @default.
• W2009352205 hasConceptScore W2009352205C42407357 @default.
• W2009352205 hasConceptScore W2009352205C71924100 @default.
• W2009352205 hasConceptScore W2009352205C98274493 @default.
• W2009352205 hasIssue "12" @default.
• W2009352205 hasLocation W20093522051 @default.
• W2009352205 hasLocation W20093522052 @default.

• next